Business1 sourcesNeutral

ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis

/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new long-term 52-week data from the Phase 3 ICONIC-ADVANCE 1 and 2 and ICONIC-LEAD studies, which...

PR Newswire

via PR Newswire

March 28, 2026 | 2:00 PM UTCUpdated 2h ago

Share Read original

Read the full article at PR Newswire →

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

PR Newswire

GNews

Comments

0 comments

Be respectful and constructive.

Loading comments...

AEW Collision Preview: March 28, 2026 - Okada vs. Knight for International Title, Divine Dominion vs. Babes of Wrath for Tag Team Titles, More

Business

ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis

Source Verification

Comments

AEW Collision Preview: March 28, 2026 - Okada vs. Knight for International Title, Divine Dominion vs. Babes of Wrath for Tag Team Titles, More

1 person killed in crash that shut down 610 West Loop southbound in Galleria Area, HPD says

Related Articles

Who in Big Tech Is Ready for Agentic AI?

Thieves steal 12 tons of KitKat bars from truck in Europe

Thank you for calling Epstein Island at 1600 Pensylvania Ave [Amusing]